SCHEMBL23502576

SCHEMBL23502576

CCCCCC(C)(CCC)c1cnc2cc(C(C)(CC)CCC)cc(Cl)c2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23502514 0.87 TLR8 (0.31) —
SCHEMBL20047669 0.85 TLR8 (0.31) —
SCHEMBL23502569 0.83 TLR8 (0.32) —
SCHEMBL23502591 0.83 — —
SCHEMBL23502551 0.82 CNR2 (0.38) —
SCHEMBL23502553 0.80 CNR1 (0.33) —
SCHEMBL23502431 0.78 CNR2 (0.34) —
SCHEMBL23502550 0.78 PDE4A (0.31) —
SCHEMBL23502571 0.77 TLR7 (0.32) —
SCHEMBL23502581 0.76 ESR1 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11034684-B2 Isoxazole analogs as FXR agonists and methods of use thereof ENANTA PHARMACEUTICALS, INC. (US) 2021-06-15 — — US disclosed
Send feedback